More on CRSP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+50.0% Growth)
- Ratings (5.6 Score)
- Holders

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CRISPR Therapeutics (NQ:CRSP)
Delayed: 53.35 +1.33 (2.56%)
Prev. Close $52.02  
Open$52.59 
52 Wk High$18.88 
52 Wk Low$13.75 
Day High$55.10 
Day Low$51.64 
P/E N/A  
EPS$0.00 
Volume1,509,271 

Friends, Peers and Foes (?): NTLA, BEAM, EDIT, DTIL, MGX (more...)

Jun 12, 2026 04:11 AM CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
Jun 11, 2026 04:23 AM Morgan Stanley Assumes CRISPR Therapeutics (CRSP) at Equalweight
Jun 9, 2026 06:09 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: George Simeon
Jun 9, 2026 06:06 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Behbahani Ali
Jun 9, 2026 05:44 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Fardis Maria
Jun 9, 2026 05:43 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Fleming Harold Edward
Jun 9, 2026 05:43 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Greene John
Jun 9, 2026 05:42 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: High Katherine A
Jun 9, 2026 05:42 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Mahatme Sandesh
Jun 9, 2026 05:41 PM Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Morrison Briggs
View All Articles

Entities mentioned with CRSP

View All Entities